Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Acker

Thoracic Surgery (Cardiothoracic Vascular Surgery) Philadelphia, PA Medical Doctor

NPI 1568494870 CMS profile 298088

3400 Spruce Street, 6 Silverstein Bldg, Philadelphia, PA 19104

Open in the dashboard

General payments

$271,181

75 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$300,000

6 holdings reported · through program year 2025

Research they led as principal investigator

$257,455 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Michael Acker of Philadelphia, PA is reported in the CMS Open Payments database as having received $271,181 across 75 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $257,455 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $300,000 across 6 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $14,694 16
2024 General $9,080 21
2023 General $1,736 12
2022 General $4,306 20
2021 General $151 2
2020 General $36 1
2019 General $241,177 3
2025 Ownership $50,000 1
2024 Ownership $50,000 1
2023 Ownership $50,000 1
2022 Ownership $50,000 1
2021 Ownership $50,000 1
2020 Ownership $50,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Acker
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Michael Acker were reported at $14,694. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Michael Acker Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $241,177 $886 $178–$3,167 $163
2020 $36 $341 $108–$1,605 $114
2021 $151 $453 $125–$1,886 $132
2022 $4,306 $695 $180–$2,566 $149
2023 $1,736 $745 $205–$2,662 $160
2024 $9,080 $799 $214–$2,967 $164
2025 $14,694 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $269,519 61 payments
  2. Abbott Laboratories $687 4 payments
  3. CryoLife, Inc. $259 2 payments
  4. Medtronic, Inc. $236 2 payments
  5. Corcym Inc $147 2 payments
  6. Abiomed $127 1 payment
  7. Cook Medical LLC $108 1 payment
  8. Baxter Healthcare $97 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $241,069 1 payment
  2. Consulting Fee $19,250 7 payments
  3. Travel and Lodging $7,966 21 payments
  4. Food and Beverage $2,896 46 payments
Products named General payments · program years 2019–2025
  1. MITRIS RESILIA Mitral Valve $5,237 28 payments
  2. TENDYNE $612 2 payments
  3. PERCEVAL $147 2 payments
  4. CRYOVALVE SG PULMONARY HUMAN HEART VALVE $142 1 payment
  5. COREVALVE EVOLUT R $131 1 payment
  6. Impella $127 1 payment
  7. Cardiac non-SynerGraft $117 1 payment
  8. COOK $108 1 payment
  9. Mosaic $105 1 payment
  10. INSPIRIS RESILIA aortic valve $67 1 payment
  11. Other $172 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$318,426

Medicare's payments for the services billed

Medicare patients

212

Average age 73

Services billed

525

111 women, 101 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 61%
Atrial fibrillation 54%
Arthritis 47%
Chronic kidney disease 36%
Diabetes 33%
Depression 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

75 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record